The role of antioxidant therapy in the treatment of male infertility: an overview

来源 :亚洲男性学杂志(英文版) | 被引量 : 0次 | 上传用户:yibola2008
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
In recent years,many studies have focused on the effect of oxidative stress,reactive oxygen species (ROS) and antioxidants on the male eproductive system.Under physiological conditions,sperm produces small amounts of ROS,which are needed for fertilisation,acrosome reaction and capacitation.However,if an increased production of ROS is not associated with a similar increase in scavenging systems,peroxidative damage of the sperm plasma membrane and loss of DNA integrity typically occur,which leads to cell death and reduced fertility.Furthermore,since there is no linear correlation between sperm quality and pregnancy rates,an improvement in semen parameters should not be the sole outcome considered in studies of antioxidant therapies.A definitive conclusion regarding the benefit of these therapies is difficult to obtain,as most of the previous studies lacked control groups,considered different antioxidants in different combinations and doses,or did not evaluate pregnancy rates in previously infertile couples.Even if beneficial effects were reported in a few cases of male infertility,more multicentre,double-blind studies performed with the same criteria are necessary for an increased understanding of the effects of various antioxidants on fertility.
其他文献
The usefulness of diffusion-weighted magnetic resonance imaging (DWI) in the evaluation of scrotal pathology has recently been reported. A standard reference of normal testicular apparent diffusion coefifcient (ADC) values and their variations with age is
Until recently,docetaxel-based therapy represented the only therapy shown to prolong survival in patients with metastatic castration-resistant prostate cancer (mCRPC).The past year and a half has been marked by unprecedented progress in treatments for thi
We have analysed the reasons for the low reported incidence of prostate cancer in China and argue for early diagnosis and treatment of this disease.According to the 2002 database of the International Agency for Research on Cancer (IARC),the age-standardiz